Hypoxia-inducible factor as a physiological regulator

Experimental Physiology

Volumn 90, Issue 6, 2005, Pages 791-797

  Maxwell, Patrick H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1;

APOPTOSIS; CAENORHABDITIS ELEGANS; CELL FUNCTION; CELL TYPE; DROSOPHILA MELANOGASTER; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; OXYGEN TRANSPORT; OXYGENATION; REVIEW;

EID: 27844612117     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2005.030924     Document Type: Review

References (46)

1. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y et al. (2002). Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32, 614-621.
2. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW et al. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279, 38458-38465.
3. Berra E, Benizri E, Ginouves A, Volmat V, Roux D & Pouyssegur J (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 22, 4082-4090.
4. Biju MP, Neumann AK, Bensinger SJ, Johnson RS, Turka LA & Haase VH (2004). Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol Cell Biol 24, 9038-9047.
5. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH et al. (2003). Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 111, 1519-1527.
6. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H et al. (2003). Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108, 79-85.
7. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858-864.
8. Clifford SC, Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH et al. (2001). Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Human Mol Genet 10, 1029-1038.
9. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H et al. (2002). Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8, 702-710.
10. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N et al. (2003). HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
11. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A et al. (1997). Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94, 9102-9107.
12. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C et al. (2005). Brain-specific knock-out of hypoxia-inducible factor-1α reduces rather than increases hypoxic-ischemic damage. J Neurosci 25, 4099-4107.
13. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M & Kaelin WGJ (2001). von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Human Mol Genet 10, 1019-1027.
14. Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, Young LH et al. (2004). Cardiac myocyte-specific HIF-1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 18, 1138-1140.
15. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL et al. (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153.
16. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, Kondo K et al. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proceedings of the Natl Acad Sci U S A 99, 13459-13464.
17. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP & Haase VH (2004). Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114, 1098-1106.
18. Kline DD, Peng Y-J, Manola DJ, Semenza GL & Prabhakar NR (2002). Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci USA 99, 821-826.
19. Knowles HJ, Raval RR, Harris AL & Ratcliffe PJ (2003). Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63, 1764-1768.
20. Kondo K, Kim W, Lechpammer M & Kaelin W (2003). Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth. PLoS Biol 1, 439-444.
21. Lopez-Barneo J, del Toro R, Levitsky KL, Chiara MD & Ortega-Saenz P (2004). Regulation of oxygen sensing by ion channels. J Appl Physiol 96, 1187-1195; discussion 1170-1182.
22. Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM et al. (2002). HIF activation identifies early lesions in VHL kidneys. Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1, 459-468.
23. Marsh S, Nakhoul FM, Skorecki K, Rubin A, Miller BP, Leibu R et al. (2000). Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Diabetes Care 23, 1375-1380.
24. Mason SD, Hewlett RA, Kim MJ, Olfert IM, Hogan MC, McNulty W et al. (2004). Loss of skeletal muscle HIF-1α results in altered exercise endurance. PLoS Biol 2, e288.
25. Peng J, Zhang L, Drysdale L & Fong GH (2000). The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci USA 97, 8386-8391.
26. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL et al. (2005). Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25, 5675-5686.
27. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U et al. (2002). Expression of hypoxia-inducible factor-1α and -2α in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13, 1721-1732.
28. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M & Johnson RS (2001). Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev 15, 2865-2876.
29. Schofield CJ & Ratcliffe PJ (2004). Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5, 343-354.
30. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K et al. (1999). Inter individual heterogeneity in the hypoxic regulation of VEGF. Significance for the development of the coronary artery collateral circulation. Circulation 100, 547-552.
31. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ et al. (2003a). Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 35, 331-340.
32. Scortegagna M, Morris MA, Oktay Y, Bennett M & Garcia JA (2003&). The HIF family member EPAS1/HIF-27alpha; is required for normal hematopoiesis in mice. Blood 102, 1634-1640.
33. Seagroves TN, Hadsell D, McManaman J, Palmer C, Liao D, McNulty W et al. (2003). HIF1α is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130, 1713-1724.
34. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD et al. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77-85.
35. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R et al. (1999). Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 103, 691-696.
36. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C et al. (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15, 2445-2453.
37. Talks K, Turley H, Gatter KC, Maxwell PH, Pugh CW et al. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157, 411-421.
38. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T et al. (2003). Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24, 1779-1783.
39. Tian H, Hammer RE, Matsumoto AM, Russell DW & McKnight SL (1998). The hypoxia responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12, 3320-3324.
40. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T et al. (2005). Hypoxia-induced neutrophil survival is mediated by HIF-1{α}-dependent NF-{κ}B activity. J Exp Med 201, 105-115.
41. 2 tension. Proc Natl Acad Sci USA 92, 5510-5514.
42. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U et al. (2004). Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS 1) by the use of RNA interference: erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J 18, 1462-1464.
43. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze C, Horstrup JH, Warnecke C et al. (2003). Widespread, hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 17, 271-273.
44. Wiesener MS & Maxwell PH (2003). HIF and oxygen sensing; as important to life as the air we breathe? Ann Med 35, 183-190.
45. Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N et al. (2005). Genetic variation in the HIF-1α gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab.
46. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al. (1999). Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59, 5830-5835.